Serum Levels of Matrix Metalloproteinase-2 as a Marker of Intimal Hyperplasia

Journal of Surgical Research

Volumn 160, Issue 1, 2010, Pages 9-13

  Tummers, A Mike ^a   Mountain, Deidra J H ^a   Mix, J William ^a   Kirkpatrick, Stacy S ^a   Cassada, David C ^a   Stevens, Scott L ^a   Freeman, Michael B ^a   Goldman, Mitchell H ^a   Grandas, Oscar H ^a  

^a UNIVERSITY OF TENNESSEE GRADUATE SCHOOL OF MEDICINE   (United States)

Author keywords

biomarkers; intimal hyperplasia; MMPs

Indexed keywords

C REACTIVE PROTEIN; COLLAGEN TYPE 4; GELATINASE A; GELATINASE B; INTERLEUKIN 1BETA; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY INTIMA PROLIFERATION; ARTICLE; BLOOD SAMPLING; CAROTID ARTERY; ENZYME BLOOD LEVEL; FEMALE; NONHUMAN; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; RAT;

ANIMALS; BIOLOGICAL MARKERS; CAROTID ARTERY INJURIES; COLLAGEN TYPE IV; CYTOKINES; FEMALE; HYPERPLASIA; MATRIX METALLOPROTEINASE 2; POSTOPERATIVE PERIOD; RATS; RATS, SPRAGUE-DAWLEY; TUNICA INTIMA;

EID: 77950189040     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2009.04.003     Document Type: Article

References (22)

1. Yoshida Y., Mitsumata M., Ling G., et al. Migration of medial smooth muscle cells to the intima after balloon injury. Ann N Y Acad Sci 811 (1997) 459
2. Liu M.W., Roubin G.S., and King III S.B. Restenosis after coronary angioplasty. Potential biologic determinants and role of intimal hyperplasia. Circulation 79 (1989) 1374
3. Galis Z.S., and Khatri J.J. Matrix metalloproteinases in vascular remodeling and atherogenesis: The good, the bad, and the ugly. Circ Res 90 (2002) 251
4. Lin S.J., Yen H.T., Chen Y.H., et al. Expression of interleukin-1β and interleukin-1 receptor antagonist in oxLDL-treated human aortic smooth muscle cells and in the neointima of cholesterol-fed endothelia-denuded rabbits. J Cell Biochem 88 (2003) 836
5. Martinez-Gonzalez J., Llorente-Cortes V., and Badimon L. [Cellular and molecular biology of atherosclerotic lesions]. Rev Esp Cardiol 54 (2001) 218
6. Francis S.E., Camp N.J., Dewberry R.M., et al. Interleukin-1 receptor antagonist gene polymorphism and coronary artery disease. Circulation 99 (1999) 861
7. Zempo N., Koyama N., Kenagy R.D., et al. Regulation of vascular smooth muscle cell migration and proliferation in vitro and in injured rat arteries by a synthetic matrix metalloproteinase inhibitor. Arterioscler Thromb Vasc Biol 16 (1996) 28
8. Bendeck M.P., Irvin C., and Reidy M.A. Inhibition of matrix metalloproteinase activity inhibits smooth muscle cell migration but not neointimal thickening after arterial injury. Circ Res 78 (1996) 38
9. Ries C., and Petrides P.E. Cytokine regulation of matrix metalloproteinase activity and its regulatory dysfunction in disease. Biol Chem Hoppe Seyler 376 (1995) 345
10. Newby A.C. Dual role of matrix metalloproteinases (matrixins) in intimal thickening and atherosclerotic plaque rupture. Physiol Rev 85 (2005) 1
11. Hobeika M.J., Thompson R.W., Muhs B.E., et al. Matrix metalloproteinases in peripheral vascular disease. J Vasc Surg 45 (2007) 849
12. Nagase H., and Woessner Jr. J.F. Matrix metalloproteinases. J Biol Chem 274 (1999) 21491
13. Westermarck J., and Kahari V.M. Regulation of matrix metalloproteinase expression in tumor invasion. Faseb J 13 (1999) 781
14. Siwik D.A., Chang D.L., and Colucci W.S. Interleukin-1β and tumor necrosis factor-α decrease collagen synthesis and increase matrix metalloproteinase activity in cardiac fibroblasts in vitro. Circ Res 86 (2000) 1259
15. Mountain D.J., Singh M., Menon B., et al. Interleukin-1β increases expression and activity of matrix metalloproteinase-2 in cardiac microvascular endothelial cells: role of PKCα/β1 and MAPKs. Am J Physiol Cell Physiol 292 (2007) C867
16. Grandas O.H., Mountain D.J., Kirkpatrick S.S., et al. Effect of hormones on matrix metalloproteinases gene regulation in human aortic smooth muscle cells. J Surg Res 148 (2008) 94
17. Grandas O.H., Mountain D.H., Kirkpatrick S.S., et al. Regulation of vascular smooth muscle cell expression and function of matrix metalloproteinases is mediated by estrogen and progesterone exposure. J Vasc Surg 49 (2009) 185
18. Lynch C.C., and Matrisian L.M. Matrix metalloproteinases in tumor-host cell communication. Differentiation 70 (2002) 561
19. Tatsumi C., Kudo M., Ueshima K., et al. Noninvasive evaluation of hepatic fibrosis using serum fibrotic markers, transient elastography (FibroScan) and real-time tissue elastography. Intervirology 51 Suppl 1 (2008) 27
20. Acera A., Rocha G., Vecino E., et al. Inflammatory markers in the tears of patients with ocular surface disease. Ophthalmic Res 40 (2008) 315
21. Arroyo C.M., Burman D.L., Kahler D.W., et al. TNF-α expression patterns as potential molecular biomarker for human skin cells exposed to vesicant chemical warfare agents: sulfur mustard (HD) and Lewisite (L). Cell Biol Toxicol 20 (2004) 345
22. Jarosz A., and Nowicka G. [C-reactive protein and homocysteine as risk factors of atherosclerosis]. Przegl Lek 65 (2008) 268